{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T08:22:46Z","timestamp":1742804566889,"version":"3.37.3"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T00:00:00Z","timestamp":1583452800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T00:00:00Z","timestamp":1583452800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s40261-020-00897-4","type":"journal-article","created":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T16:04:49Z","timestamp":1583510689000},"page":"335-341","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Direct Medical Costs of Spinal Muscular Atrophy in the Catalonia Region: A Population-Based Analysis"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2371-0999","authenticated-orcid":false,"given":"Josep","family":"Darb\u00e0","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,6]]},"reference":[{"issue":"5","key":"897_CR1","doi-asserted-by":"publisher","first-page":"e020907","DOI":"10.1136\/bmjopen-2017-020907","volume":"8","author":"MA Farrar","year":"2018","unstructured":"Farrar MA, Carey KA, Paguinto SG, Chambers G, Kasparian NA. Financial, opportunity and psychosocial costs of spinal muscular atrophy: an exploratory qualitative analysis of Australian carer perspectives. BMJ Open. 2018;8(5):e020907.","journal-title":"BMJ Open"},{"issue":"3","key":"897_CR2","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.phr.2004.04.005","volume":"119","author":"G Anderson","year":"2004","unstructured":"Anderson G, Horvath J. The growing burden of chronic disease in America. Public Health Rep. 2004;119(3):263\u201370.","journal-title":"Public Health Rep"},{"key":"897_CR3","volume-title":"Estrategia para el abordaje de la cronicidad en el Sistema Nacional de Salud. [Strategy for Chronic care management in the Spanish National Health Service]","author":"Ministerio de Sanidad, Servicios Sociales e Igualdad","year":"2012","unstructured":"Ministerio de Sanidad, Servicios Sociales e Igualdad. Estrategia para el abordaje de la cronicidad en el Sistema Nacional de Salud. [Strategy for Chronic care management in the Spanish National Health Service]. Madrid: Ministerio de Sanidad, Servicios Sociales e Igualdad; 2012."},{"issue":"1","key":"897_CR4","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13023-017-0671-8","volume":"12","author":"IEC Verhaart","year":"2017","unstructured":"Verhaart IEC, Robertson A, Wilson IJ, Aartsma-Rus A, Cameron S, Jones CC. Prevalence, incidence and carrier frequency of 5q-linked spinal muscular atrophy: a literature review. Orphanet J Rare Dis. 2017;12(1):124.","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"897_CR5","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.ncl.2015.07.004","volume":"33","author":"SJ Kolb","year":"2015","unstructured":"Kolb SJ, Kissel JT. Spinal muscular atrophy. Neurol Clin. 2015;33(4):831\u201346.","journal-title":"Neurol Clin"},{"issue":"1","key":"897_CR6","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13023-017-0695-0","volume":"12","author":"J L\u00f3pez-Bastida","year":"2017","unstructured":"L\u00f3pez-Bastida J, Pe\u00f1a-Longobardo LM, Aranda-Reneo I, Tizzano E, Sefton M, Oliva-Moreno J. Social\/economic costs and health-related quality of life in patients with spinal muscular atrophy (SMA) in Spain. Orphanet J Rare Dis. 2017;12(1):141.","journal-title":"Orphanet J Rare Dis"},{"key":"897_CR7","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2147\/RMHP.S97248","volume":"9","author":"SM McPhail","year":"2016","unstructured":"McPhail SM. Multimorbidity in chronic disease: impact on health care resources and costs. Risk Manag Healthc Policy. 2016;9:143\u201356.","journal-title":"Risk Manag Healthc Policy"},{"issue":"6","key":"897_CR8","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/S0022-3476(89)80740-1","volume":"115","author":"IS Gilgoff","year":"1989","unstructured":"Gilgoff IS, Kahlstrom E, MacLaughlin E, Keens TG. Long-term ventilatory support in spinal muscular atrophy. J Pediatr. 1989;115(6):904\u20139.","journal-title":"J Pediatr"},{"issue":"2","key":"897_CR9","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s41669-018-0093-0","volume":"3","author":"J Cardenas","year":"2019","unstructured":"Cardenas J, Menier M, Heitzer MD, Sproule DM. High healthcare resource use in hospitalized patients with a diagnosis of spinal muscular atrophy type 1 (SMA1): retrospective analysis of the Kids\u2019 Inpatient Database (KID). Pharmacoecon Open. 2019;3(2):205\u201313.","journal-title":"Pharmacoecon Open"},{"issue":"6","key":"897_CR10","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.nmd.2017.02.014","volume":"27","author":"RS Finkel","year":"2017","unstructured":"Finkel RS, Sejersen T, Mercuri E, ENMC SMA Workshop Study Group. 218th ENMC International Workshop: revisiting the consensus on standards of care in SMA Naarden, The Netherlands, 19\u201321 February 2016. Neuromuscul Disord. 2017;27(6):596\u2013605.","journal-title":"Neuromuscul Disord"},{"key":"897_CR11","doi-asserted-by":"publisher","first-page":"S134","DOI":"10.1016\/j.nmd.2017.06.153","volume":"27","author":"M Catteruccia","year":"2017","unstructured":"Catteruccia M, Colia G, Bonetti A, Carlesi A, Oggiano L, La Rosa G, et al. Scoliosis is an inescapable comorbidity in SMA type II. A single center experience. Neuromuscul Disord. 2017;27:S134.","journal-title":"Neuromuscul Disord."},{"issue":"10","key":"897_CR12","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1093\/gerona\/glx178","volume":"73","author":"DL Vetrano","year":"2018","unstructured":"Vetrano DL, Calder\u00f3n-Larra\u00f1aga A, Marengoni A, Onder G, Bauer JM, Cesari M, et al. An international perspective on chronic multimorbidity: approaching the elephant in the room. J Gerontol A Biol Sci Med Sci. 2018;73(10):1350\u20136.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"897_CR13","doi-asserted-by":"publisher","first-page":"4","DOI":"10.15256\/joc.2016.6.72","volume":"6","author":"R Navickas","year":"2016","unstructured":"Navickas R, Petric VK, Feigl AB, Seychell M. Multimorbidity: what do we know? What should we do? J Comorb. 2016;6(1):4\u201311.","journal-title":"J Comorb"},{"issue":"9836","key":"897_CR14","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0140-6736(12)60240-2","volume":"380","author":"K Barnett","year":"2012","unstructured":"Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380(9836):37\u201343.","journal-title":"Lancet"},{"issue":"1","key":"897_CR15","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.healthpol.2017.10.002","volume":"122","author":"M Rijken","year":"2018","unstructured":"Rijken M, Hujala A, van Ginneken E, Melchiorre MG, Groenewegen P, Schellevis F. Managing multimorbidity: profiles of integrated care approaches targeting people with multiple chronic conditions in Europe. Health Policy. 2018;122(1):44\u201352.","journal-title":"Health Policy"},{"issue":"2","key":"897_CR16","first-page":"1","volume":"20","author":"E Bernal-Delgado","year":"2018","unstructured":"Bernal-Delgado E, Garc\u00eda-Armesto S, Oliva J, S\u00e1nchez Mart\u00ednez FI, Repullo JR, Pe\u00f1a-Longobardo LM, et al. Spain: health system review. Health Syst Trans. 2018;20(2):1\u2013179.","journal-title":"Health Syst Trans"},{"key":"897_CR17","unstructured":"Ley 14\/1986, de 25 de abril, General de Sanidad. BOE. No. 102 (1986)."},{"key":"897_CR18","unstructured":"Programa p\u00fablic d\u2019anal\u00edtica de dades per a la recerca i la innovaci\u00f3 en salut a Catalunya\u2013PADRIS. Barcelona: Ag\u00e8ncia de Qualitat i Avaluaci\u00f3 Sanit\u00e0ries de Catalunya. Departament de Salut. Generalitat de Catalunya; 2017."},{"key":"897_CR19","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2147\/JMDH.S160029","volume":"11","author":"VB Katkade","year":"2018","unstructured":"Katkade VB, Sanders KN, Zou KH. Real world data: an opportunity to supplement existing evidence for the use of long-established medicines in health care decision making. J Multidiscip Healthc. 2018;11:295\u2013304.","journal-title":"J Multidiscip Healthc"},{"key":"897_CR20","unstructured":"International classification of diseases: [9th] ninth revision, basic tabulation list with alphabetic index. Geneva: World Health Organization. https:\/\/apps.who.int\/iris\/handle\/10665\/39473?locale-attribute=en&. Accessed 23 Apr 2019."},{"issue":"10","key":"897_CR21","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.aprim.2016.06.003","volume":"48","author":"D Monterde","year":"2016","unstructured":"Monterde D, Vela E, Cl\u00e8ries M, grupo colaborativo GMA. Adjusted morbidity groups: a new multiple morbidity measurement of use in primary care [in Spanish]. Atenci\u00f3n Primaria. 2016;48(10):674\u201382.","journal-title":"Atenci\u00f3n Primaria"},{"key":"897_CR22","unstructured":"Catalunya. RESOLUCI\u00d3 SLT\/353\/2013, de 13 de febrer, sobre la revisi\u00f3 de preus p\u00fablics corresponents als serveis sanitaris que presta l\u2019Institut Catal\u00e0 de la Salut. DOGC. No. 6326 (2013)."},{"key":"897_CR23","unstructured":"Catalunya. Ordre SLT\/235\/2013, de 9 de setembre, per la qual s\u2019estableixen per a l\u2019any 2013 els valors de les unitats de pagament per a la contraprestaci\u00f3 dels serveis duts a terme pels centres sociosanitaris DOGC. No. 6478 (2013)."},{"key":"897_CR24","unstructured":"Real Decreto-ley 7\/2018, de 27 de julio, sobre el acceso universal al Sistema Nacional de Salud. BOE. No. 183 (2018)."},{"issue":"23","key":"897_CR25","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1001\/jama.2012.5265","volume":"307","author":"ME Tinetti","year":"2012","unstructured":"Tinetti ME, Fried TR, Boyd CM. Designing health care for the most common chronic condition\u2014multimorbidity. JAMA. 2012;307(23):2493\u20134.","journal-title":"JAMA"},{"issue":"5","key":"897_CR26","doi-asserted-by":"publisher","first-page":"E221","DOI":"10.1503\/cmaj.121349","volume":"185","author":"RA Payne","year":"2013","unstructured":"Payne RA, Abel GA, Guthrie B, Mercer SW. The effect of physical multimorbidity, mental health conditions and socioeconomic deprivation on unplanned admissions to hospital: a retrospective cohort study. CMAJ. 2013;185(5):E221\u20138.","journal-title":"CMAJ"},{"key":"897_CR27","unstructured":"Informe del proyecto de Estratificaci\u00f3n de la Poblaci\u00f3n por Grupos de Morbilidad Ajustados (GMA) en el Sistema Nacional de Salud (2014\u20132016). Ministerio de Sanidad; 2018."},{"issue":"2","key":"897_CR28","first-page":"67","volume":"63","author":"B White","year":"2014","unstructured":"White B, Carney P, Flynn J, Marino M, Fields S. Reducing hospital readmissions through primary care practice transformation. J Fam Pract. 2014;63(2):67\u201373.","journal-title":"J Fam Pract"},{"issue":"654","key":"897_CR29","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.3399\/bjgp16X687949","volume":"67","author":"J Busby","year":"2017","unstructured":"Busby J, Purdy S, Hollingworth W. Opportunities for primary care to reduce hospital admissions: a cross-sectional study of geographical variation. Br J Gen Pract. 2017;67(654):e20\u20138.","journal-title":"Br J Gen Pract"},{"issue":"1","key":"897_CR30","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13023-016-0424-0","volume":"11","author":"C Klug","year":"2016","unstructured":"Klug C, Schreiber-Katz O, Thiele S, Schorling E, Zowe J, Reilich P, et al. Disease burden of spinal muscular atrophy in Germany. Orphanet J Rare Dis. 2016;11(1):58.","journal-title":"Orphanet J Rare Dis"},{"key":"897_CR31","first-page":"16 Suppl","volume":"88","author":"M Teynor","year":"2017","unstructured":"Teynor M, Hou Q, Zhou J, Hall E, Wells W, Avendano J. Healthcare resource use in patients with diagnosis of spinal muscular atrophy (SMA) in Optum\u2122 U.S. Claims Database (P4.158). Neurology. 2017;88:16 Suppl.","journal-title":"Neurology"},{"key":"897_CR32","unstructured":"Ministerio de Sanidad, Consumo y Bienestar Social. Sanidad en datos. https:\/\/www.mscbs.gob.es\/estadEstudios\/sanidadDatos\/home.htm. Accessed 13 Dec 2019."},{"issue":"6","key":"897_CR33","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1089\/adt.2014.587","volume":"12","author":"JJ Cherry","year":"2014","unstructured":"Cherry JJ, Kobayashi DT, Lynes MM, Naryshkin NN, Tiziano FD, Zaworski PG, et al. Assays for the identification and prioritization of drug candidates for spinal muscular atrophy. Assay Drug Dev Technol. 2014;12(6):315\u201341.","journal-title":"Assay Drug Dev Technol"},{"issue":"1","key":"897_CR34","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1177\/1060028018789956","volume":"53","author":"MK Claborn","year":"2019","unstructured":"Claborn MK, Stevens DL, Walker CK, Gildon BL. Nusinersen: a treatment for spinal muscular atrophy. Ann Pharmacother. 2019;53(1):61\u20139.","journal-title":"Ann Pharmacother"},{"key":"897_CR35","unstructured":"Informe de Posicionamiento Terap\u00e9utico de nusinersen (Spinraza\u00ae) en atrofia muscular espinal. Informe de posicionamiento terap\u00e9utico. Ministerio de Sanidad, Servicios sociales e Igualdad y Agencia Espa\u00f1ola de medicamentos y productos sanitarios. 2018; IPT, 5\/2018. V1."}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-020-00897-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40261-020-00897-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-020-00897-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,6]],"date-time":"2021-03-06T00:14:39Z","timestamp":1614989679000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40261-020-00897-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,6]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["897"],"URL":"https:\/\/doi.org\/10.1007\/s40261-020-00897-4","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"type":"print","value":"1173-2563"},{"type":"electronic","value":"1179-1918"}],"subject":[],"published":{"date-parts":[[2020,3,6]]},"assertion":[{"value":"6 March 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Josep Darb\u00e0 declares that no conflicts of interest exist.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This project was approved by the University of Barcelona\u2019s Bioethics Commission. Data were anonymised prior to extraction in accordance with the Declaration of Helsinki and Spanish legislation (Law 14\/2007, 3 July, on biomedical research, Spain). Patient consent was not required for this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}},{"value":"The author received no specific funding for this work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}}]}}